Stay updated on Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.

Latest updates to the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading; it also updates the revision label to v3.6.0 and notes that recruitment is closed with a 'No longer looking for participants' statement.SummaryDifference0.4%

- Check20 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a minor administrative update. No study content or data were changed.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page update introduces revision v3.5.4, replacing the previous v3.5.3. This appears to be a metadata/versioning change without visible user-facing content alterations.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a website release rather than a change to the clinical trial information.SummaryDifference0.1%

- Check71 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.